The Department of Medical Sciences of the RAS, Therapeutic Sciences Council meeting: Scientific projects marathon of Russian therapeutic departments "From innovative technologies and education to healthcare practice. Pulmonology: from real clinical practice to promising developments"

Council for Therapeutic Sciences of the Russian Academy of Sciences, pulmonology, bronchial asthma, cough, cardiorespiratory analysis

1. Naumova V, Beltyukov E, Niespodziana K, et al. Cumulative IgElevels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma. Front Immunol. 2022;13:941492. doi:10.3389/fimmu.2022.941492.

2. Naumova VV, Beltyukov EK, Kiseleva DV. Efficacy of anti-IL-5 therapy with mepolizumab for severe bronchial asthma and concomitant inflammatory nasal diseases in real clinical practice. Russian Journal of Allergy. 2022;19(1):67-79. (In Russ.) doi:10.36691/RJA1519.

3. Naumova VV, Kiseleva DV, Beltyukov EK, Starikova YaR. AntiIL-4,13 strategy in management of comormid patients in the regional register of severe bronchial asthma. Russian Journal of Allergy. 2022;19(4):435-46. (In Russ.) doi:10.36691/RJA1580.

4. Naumova VV, Beltyukov EK, Abdullaev VCh, et al. Efficacy of twoyear anti-IgE therapy in patients with severe allergic bronchial asthma in Sverdlovsk region. Meditsinskiy Sovet. 2023;17(4):8-17. (In Russ.) doi:10.21518/ms2023-050.

5. Naumova VV, Beltyukov ЕК, Kovtun ОP, et al. Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma. Meditsinskiy Sovet. 2023;17(20):18-27. (In Russ.) doi:10.21518/ms2023-308.

6. Naumova VV, Beltyukov ЕК, Kovtun ОP, et al. Direct comparative study of anti-IgE and anti-IL4Rα therapy effectiveness in patients with severe allergic and mixed bronchial asthma. Meditsinskiy Sovet. 2024;18(9):74-86. (In Russ.) doi:10.21518/ms2024-195.

7. Naumova VV, Beltyukov EK, Kiseleva DV, et al. Targeted therapy for severe asthma: switching biological agents in real clinical practice, causes, and consequences. Russian Journal of Allergy. 2023;20(4):439-54. (In Russ.) doi:10.36691/RJA15993.

8. Menzies-Gow AN, McBrien C, Unni B, et al. Real world biologic use and switch patterns in severe asthma: Data from the international severe asthma registry and the US CHRONICLE study. J Asthma Allergy. 2022;15:63-78. doi:10.2147/JAA.S328653.

9. Song WJ, Chang YS, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and metaanalysis. Eur Respir J. 2015;45(5):1479-81. doi:10.1183/09031936.00218714.

10. Morice AH, Millqvist E, Bieksiene K, et al. European Respiratory Society guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur. Respir. J. 2020;55:1901136. doi:10.1183/13993003.01136-2019.

11. Hoglund NJ, Michaelsson M. A method for determining the cough threshold with some preliminary experiments on the effect of codeine. Acta Physiol Scand. 1950;21(2-3):168-73. doi:10.1111/j.1748-1716.1950.tb00724.x.

12. Thomas J, Heurich AE, Shepherd DA, Sanzari NP. A system for the clinical assessment of the antitussive activity of caramiphen. Curr Ther Resp. 1974;10:1082-90.

13. Provotorov VM, Bilchenko LV, Romashov BB. Peculiarities of spectral tussography in patients with bronchial asthma and diabetes. Pulmonologiya. 2000;(2):56-62. (In Russ.)

14. Budnevsky AV, Avdeev SN, Ovsyannikov ES, et al. Spectral analysis of cough sounds of patients with COVID-19. PULMONOLOGIYA. 2022;32(6):834-41. (In Russ.) doi:10.18093/0869-0189-2022-32-6-834-841.

15. Ovsyannikov ES, Avdeev SN, Budnevsky AV, Shkatova YS. Influence of Anxiety/Depression on the Subjective Evaluation of Cough in Patients with Chronic Obstructive Pulmonary Disease and Obesity. Medicina (Kaunas). 2019;55(5):134. doi:10.3390/medicina55050134.

16. Budnevsky AV, Ovsyannikov ES, Avdeev SN, et al. The role of spectral analysis of cough sounds in the diagnosis of COVID-19. Terapevticheskii Arkhiv (Ter. Arkh.). 2024;96(3):228-32. (In Russ.) doi:10.26442/00403660.2024.03.202636.

17. Bubnova MG, Persianova-Dubrova AL. Application of the sixminute walk test in cardiac rehabilitation. Cardiovascular Therapy and Prevention. 2020;19(4):2561. (In Russ.) doi:10.15829/17288800-2020-2561.

18. Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572-80. doi:10.1016/s0140-6736(17)32520-5.

19. Budnevsky AV, Kravchenko AYa, Tokmachev RE, et al. Diagnostic, prognostic and therapeutic possibilities of using the 6-minute walk test in patients with chronic heart failure. Cardiovascular Therapy and Prevention. 2020;19(6):2460. (In Russ.) doi:10.15829/1728-8800-2020-2460.

20. Tokmachev RE, Mukhortova MS, Budnevsky AV, et al. Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics. Cardiovascular Therapy and Prevention. 2018;17(6):62-8. (In Russ.) doi:10.15829/1728-8800-2018-6-62-68.

21. Tokmachev RE, Kravchenko AYa, Budnevsky AV. Chronic heart failure with metabolic syndrome: optimization of medical and preventive measures. System analysis and management in biomedical systems. 2017;16(3):493-502. (In Russ.)